某“三甲”医院2010—2012年中药注射剂应用分析

Utilization of Traditional Chinese Medicine Injection in a“Three-A”Hospital from 2010 to 2012

目的:了解某"三甲"医院2010—2012年中药注射剂的应用情况。方法:对该院2010—2012年中药注射剂的销售金额、用药频度(DDDs)及药品日均费用(DDC)进行统计分析。结果:2010—2012年中药注射剂应用逐年增加,其销售金额年增长率分别为14.82%和25.34%,DDDs年增长率分别为12.05%和26.30%;心脑血管类中药注射剂销售金额和DDDs在各年度排序位居首位;痰热清注射剂的DDDs增长最快,2012年位居首位,参麦注射剂与苦碟子注射剂各年度DDDs均位于前3位;抗肿瘤类中药注射剂DDC较高,其中以康莱特注射剂最高。结论:该院中药注射剂应用基本合理,呈不断增长趋势,部分中药注射剂可能存在过度使用。应加强对中药注射剂合理使用的监管,确保其临床使用安全、有效。

OBJECTIVE：To investigate the utilization of traditional Chinese medicine injection（TCMI）in a＂Three-A＂hospital from 2010 to 2012. METHODS：The utilization of TCMI in the＂Three-A＂hospital from 2010 to 2012 was analyzed in respects of consumption sum,DDDs and DDC. RESULTS：The consumption sum of TCMI increased year by year during 2010-2012,with annual incremental rates of 14.82% and 25.34%,and the annual incremental rates in DDDs were 12.05% and 26.30% respectively. The TCMI for cardio-cerebrovascular diseases dominated the first place in terms of both consumption sum and DDDs over the three years. The DDDs of Tanreqing injection showed the fastest increase and dominated the first place in 2012. The DDDs of Shenmai injection and Ixeris Sonchifolia injection took the top three places on the list of DDDs each year. Anti-tumor TCMI took the lead in DDC with Kanglaite injection showing the highest DDC. CONCLUSIONS：The utilization of TCMI in the hospital was reasonable basically with year-on-year increasing trend. However,some TCMIs were overused. Therefore,Efforts should be taken to tighten control on the rational use of TCMI so as to ensure safe and effective use of TCMI.